We are live on ! Find out more
PRQR icon

ProQR Therapeutics

44 hedge funds and large institutions have $161M invested in ProQR Therapeutics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1.65% less ownership

Funds ownership: 61.07%59.42% (-1.6%)

14% less funds holding

Funds holding: 5144 (-7)

26% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 19

45% less call options, than puts

Call options by funds: $80K | Put options by funds: $146K

46% less capital invested

Capital invested by funds: $299M → $161M (-$138M)

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
44
Holders Change
-7
Holders Change %
-13.73%
% of All Funds
0.97%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
4
Increased
14
Reduced
19
Closed
11
Calls
$80K
Puts
$146K
Net Calls
-$66K
Net Calls Change
-$73K
Name Holding Trade Value Shares
Change
Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$134K -$550K -71,670 -75%
Simplex Trading
27
Simplex Trading
Illinois
$134K +$188K +24,484 New
AG
28
Aperio Group
California
$116K +$162K +21,112 New
Mirae Asset Global Investments
29
Mirae Asset Global Investments
South Korea
$87K +$13.1K +1,711 +12%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$85K +$105K +13,656 +782%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$70K -$30.6K -3,990 -24%
Wells Fargo
32
Wells Fargo
California
$65K
State Street
33
State Street
Massachusetts
$61K -$6.12K -798 -7%
Citigroup
34
Citigroup
New York
$39K +$25.3K +3,296 +86%
Group One Trading
35
Group One Trading
Illinois
$31K -$202K -26,284 -82%
CG
36
Cutler Group
California
$20K +$29.2K +3,800 New
Barclays
37
Barclays
United Kingdom
$18K +$23K +3,003 +858%
LC
38
Lindbrook Capital
California
$5K -$4.32K -563 -40%
ClearBridge Investments
39
ClearBridge Investments
New York
$5K -$245 -32 -3%
US Bancorp
40
US Bancorp
Minnesota
$5K +$4.39K +572 +233%
TRCT
41
Tower Research Capital (TRC)
New York
$2K -$28.9K -3,765 -92%
PA
42
Parallel Advisors
California
$2K +$1.53K +199 +88%
S
43
SignatureFD
Georgia
$2K +$3.42K +446 New
Daiwa Securities Group
44
Daiwa Securities Group
Japan
$1K
OAM
45
Oxford Asset Management
United Kingdom
-$786K -79,336 Closed
HF
46
HRT Financial
New York
-$561K -56,682 Closed
Arrowstreet Capital
47
Arrowstreet Capital
Massachusetts
-$426K -42,947 Closed
BFM
48
Boothbay Fund Management
New York
-$357K -36,051 Closed
PP
49
Paloma Partners
Connecticut
-$199K -20,078 Closed
AAP
50
Ardsley Advisory Partners
Connecticut
-$198K -20,000 Closed

PRQR Hedge Fund Activity: Q1 2020 in Review

44 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q1 2020, worth a combined $161M — down 46% from $299M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of PRQR and 4 opened new positions — a net loss of 7 holders — while 19 trimmed existing stakes and 14 added.

The largest buyer was Aquilo Capital Management, adding an estimated $3.67M. The largest seller was Sphera Funds Management, cutting an estimated $3.52M.

  • 44 institutional investors held ProQR Therapeutics (PRQR) as of Q1 2020, down from 51 in Q4 2019.
  • Funds reported $161M of ProQR Therapeutics stock for Q1 2020, down 46% quarter-over-quarter.
  • 4 funds opened new ProQR Therapeutics positions in Q1 2020 and 11 closed out, a net change of -7 holders.
  • The largest ProQR Therapeutics buyer in Q1 2020 was Aquilo Capital Management, an estimated $3.67M added.
  • The largest ProQR Therapeutics seller in Q1 2020 was Sphera Funds Management, an estimated $3.52M sold.

Based on aggregated 13F filings for Q1 2020.